Zizhu Zhixue Ye (紫珠止血液)紫珠止血液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司
主要成分Active Ingredients
- 紫珠草叶Zizhu Caoye
药物知识说明
紫珠草叶是一种在国家药监局注册认定的药品。标注生产企业为贵州益佰制药股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司、贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司、贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 紫珠止血液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 贵州益佰制药股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司, 贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司, 贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 紫珠止血液Recorded Chinese name: 紫珠止血液
- 规格Specification: 20ml*10支20 mL × 10 units
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 贵州益佰制药股份有限公司Chinese legal name: 贵州益佰制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z52020241
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z52020241
Manufacturer
Chinese legal name: 贵州益佰制药股份有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
20 mL × 10 units
中文说明书原文Original Chinese source label
批准文号
国药准字Z52020241
生产企业
贵州益佰制药股份有限公司(国产)
功能主治
清热解毒，收敛止血。用于胃肠道出血、便血、咯血以及外伤出血等。
用法用量
口服，一次40ml，一日2～3次，亦可用胃管灌胃。外用，取本品制成纱布条使用。
不良反应
尚不明确。
禁忌
1.对本品及其成分过敏者禁用。
2.本品药性寒凉，脾胃虚寒者忌用。
3.合并有心脑血管、肝、肾和造血系统等严重原发性疾病者禁用。
4.药品性状发生改变时，口服液如有明显沉淀，出现不应有的异嗅、异味或霉变等禁止使用。
注意事项
1.过敏体质者慎用。
2.本品药性苦寒，易伤正气，体弱年迈者慎用。
3.出血量多者，应采取综合急救措施。
4.如果患有可能引起出血的其他疾病，请针对原发疾病进行相应处理。
5.出血量大时，要考虑采用局部止血快速止血。吐血量大者，应保持头低脚高侧卧位，避免血液流入气道引起窒息，同时应暂时禁食。
6.宜保持情绪平稳，避免急躁动怒。
7.用药期间，不要饮酒，吸烟。饮食宜清淡，避免辛辣香燥之品。也不要食用粗纤维食物及炙烩油煎食物。
8.用药期间，注意休息，避免劳累，保证充足的睡眠。
贮藏
遮光，密封保存。
规格
20ml*10支
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.